Article
Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double-blind, placebo-controlled trial.
Transactions of the Royal Society of Tropical Medicine and Hygiene - 1 Jan 2000
Obonyo Charles O, Ochieng Francis, Taylor Walter R J, Ochola Samuel A, Mugitu Kefas, Olliaro Piero, ter Kuile Feiko, Oloo Aggrey J
Abstract excerpt
Plasmodium falciparum has developed resistance to almost all routinely used antimalarial drugs. Sulfadoxine-pyrimethamine (SP) has replaced chloroquine as first-line treatment of uncomplicated malaria infection in Kenya but resistance to SP is already reported. The addition of artemisinin derivatives to SP may delay the development of drug resistance, improve cure rates, and reduce transmission. The efficacy and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
